FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Granules Pharmaceuticals Colchicine Capsules 0 Recall

Colchicine Capsules 0

Granules Pharmaceuticals Inc. · Chantilly, VA

Risk level
Class II
Reported by FDA
Jan 15, 2025
Recall ID
D-0187-2025
Check your lot numberHow we source this data

Summary

Granules Pharmaceuticals recalled Colchicine Capsules 0 starting Dec 18, 2024. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0187-2025 on Jan 15, 2025. Reason: Failed Dissolution Specifications: Out of specification observed during the accelerated stability conditions for the 30 count bottles. Status: Terminated.

Why it was recalled

Failed Dissolution Specifications: Out of specification observed during the accelerated stability conditions for the 30 count bottles.

Product description

Colchicine Capsules 0.6 mg, 30-count bottles, Rx only, Manufactured by: Granules Pharmaceuticals Inc. Chantilly, VA 20151 NDC 70010-001-03

Lot numbers, UPCs & expiration codes

Lot#: GPC240763B, Exp. Date 6/17/2026

Where it was sold

Nationwide within the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0187-2025
Classification
Class II
Status
Terminated
Recall initiated
Dec 18, 2024
FDA report date
Jan 15, 2025
Quantity
96 Bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Granules Pharmaceuticals Inc.

Original FDA data

Every field from FDA enforcement report D-0187-2025, exactly as published.

Show all FDA fields
City
Chantilly
State
VA
Status
Terminated
Country
United States
Event ID
96026
Address
3701 Concorde Pkwy
Code information
Lot#: GPC240763B, Exp. Date 6/17/2026
Postal code
20151-1126
Report date
Jan 15, 2025
Product type
Drugs
Recall number
D-0187-2025
Classification
Class II
Recalling firm
Granules Pharmaceuticals Inc.
Product quantity
96 Bottles
Termination date
Jul 1, 2025
Reason for recall
Failed Dissolution Specifications: Out of specification observed during the accelerated stability conditions for the 30 count bottles.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Colchicine Capsules 0.6 mg, 30-count bottles, Rx only, Manufactured by: Granules Pharmaceuticals Inc. Chantilly, VA 20151 NDC 70010-001-03
Distribution pattern
Nationwide within the United States
Recall initiation date
Dec 18, 2024
Initial firm notification
Letter
Center classification date
Jan 7, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0187-2025, published Jan 15, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls